Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mirza Nadeem Q.
Aprea Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Mirza Nadeem Q.
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hamill John P.
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gilad Oren
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hamill John P.
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Seizinger Bernd R.
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HENNEMAN JOHN B III
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gilad Oren
Aprea Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sio Capital Management, LLC(7.49%)
Aprea Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AIGH Capital Management, LLC(9.4%),Orin H(9.4%)
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pamukcu Rifat
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Grissinger Michael
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HENNEMAN JOHN B III
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Peters Richard
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Duey Marc
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Seizinger Bernd R.
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BIZZARI JEAN-PIERRE
Aprea Therapeutics | 3: Initial statement of beneficial ownership of securities-Director BIZZARI JEAN-PIERRE
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Seizinger Bernd R.
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gruia Gabriela
No Data